Success in the medical experience that improves patients with advanced breast cancer
Oral medicine was tested for daily consumption, the first of its kind, successfully: it delays the spread breast cancer Advanue and doctors believe this A revolution will take place in the treatment of thousands of people.
The experiment discovered that the medicine, VepdegestrantIt is twice more effective than existing treatments to prolong the lives of non -healing breast cancer, allowing them to get life time, and collects Tumor goal.
Experts say that Vepdengest also has Many secondary effects The drugs used today can be taken at home.
About two -thirds of breast cancer patients suffer from a negative positive disease of the disease. Among them, in the middle of the road with an advanced form that can develop a genetic mutation that makes its cancer Treatment is resistant.
Patients with this mutation, called ESR1, generally have less than two years of age. Currently, these patients receive a monthly injection called FulvestrantWhich prevents cancer cells from feeding on estrogen, a female sexual hormone, according to research, helps tumors to grow.
However, Fulvestrant, which must be managed by a health specialist, has a series of uncomfortable side effects, including suffocation, nausea and muscle aches. In some cases, You can also damage the liver. However, the injection can maintain the disease except for only two months and only one fifth of patients treated for six months without the spread of cancer.
But the article with Vepegestrant was presented at a conference The American Association for Clinical Oncology in ChicagoIt reveals that the drug has stopped the spread of breast cancer for a period of five months on average.
Moreover, nearly half 300 patients were given Vepdengest Six months passed without the spread of cancer. The study discovered that the drug, which also prevents cancer cells from consuming estrogen, has no important side effects.
Experts say it is too early to say How long does patients live? They take Vepergestrant that those who take Fulvestrant, but they expect the difference to be important.
The drug is already treated quickly For use in the United States.
The teacher says: “Fulvestrant incredibly painful and uncomfortable for patients, and most of them are forced to go to the clinic to receive it.” Kumal JHAVERI, Oncology at the Sloan Kettering Oncology Specialist in New York.
Instead, “Oral tablets can be taken from the VEPDEGESTRANT at home,” says JHAVERI. Physician Jane Chisel“This medicine will be a very exciting choice for patients and can prevent treatment,” says professor of medical oncology at Emory University at Georgia. Because it can be taken at home and does not leave patients with weak side effects, “it is certainly the first of its kind”, and concluded to say.
